ATAI: ATAI Life Sciences N.V

ATAI新闻

• 12:05 AtaiBeckley secures new patent for mental health drug EMP-01
• 22:12 Atai Beckley在收购Beckley Psytech后为已注册股份提交招股说明书补充文件
• 22:12 Atai Beckley files prospectus supplement for registered shares after Beckley Psytech acquisition
• 12:45 H.C. Wainwright维持atai Life Sciences股票买入评级
• 12:43 H.C. Wainwright reiterates Buy rating on atai Life Sciences stock
• 22:12 Atai Beckley N.V. (ATAI) Discusses BPL-003 Phase IIb Open-Label Extension Study Results in Treatment Resistant Depression - Slideshow (NASDAQ:ATAI) 2025-11-10
• 12:05 AtaiBeckley reports positive results for depression nasal spray
• 18:16 Opinion: Tech selloff breaks major S&P 500 support — but here’s when stocks really unravel
• 13:45 Atai Beckley提交招股说明书补充文件用于转售530万股股票
• 13:44 Atai Beckley files prospectus supplement for resale of 5.3 million shares
• 22:17 ATAI Life Sciences股东批准收购Beckley Psytech及公司迁址
• 22:16 ATAI Life Sciences shareholders approve acquisition of Beckley Psytech and redomiciliation
• 22:11 Opinion: Stock investors head into November saying thanks to a market that keeps on giving
• 20:52 Opinion: The end of October often rewards stock investors with this profitable trade
• 11:11 Canaccord Genuity上调atai Life Sciences股票目标价至14美元
• 11:11 Canaccord Genuity raises atai Life Sciences stock price target to $14
• 21:57 ATAI Life Sciences股价在完成1.495亿美元公开募股后上涨
• 21:56 ATAI Life Sciences stock rises after closing $149.5 million public offering
• 21:38 atai Life Sciences公开募股筹集1.495亿美元
• 21:36 atai Life Sciences raises $149.5 million in public offering